What AI Can and Can’t Do for Digital Pathology Right Now
Posted 15th July 2020 by Liv Sewell
It was fascinating to speak with Hamid Tizhoosh, Professor at the Faculty of Engineering at the University of Waterloo in Canada, Director of KIMIA Lab and keynote speaker at the 6th Digital Pathology & AI Congress: USA, about using AI to transform what is possible in medical imaging.
Digital pathology: From over-promising to a reality check
Posted 17th June 2020 by Liv Sewell
Almost five years ago, the plan to implement a wide-ranging digital pathology approach across the Netherlands began to take shape. As more labs across the country acquire digital pathology capability, with steps to create a strong and accessible image repository and a national image exchange platform, one of the project leaders, Professor Katrien Grünberg, offered an update and spoke of some challenges that still lie ahead.
What does international collaboration mean for you?
Posted 27th May 2020 by Liv Sewell
The present COVID-19 crisis has demonstrated the vital need for knowledge sharing across the global science community. We asked three of our speakers what international collaboration means for them as leaders in their fields.
COVID-19 and global collaboration in science
Posted 11th May 2020 by Liv Sewell
International collaboration and travel are integral to the life of researchers and biotechnology professionals. But coronavirus has made travel impossible.
We look back over two decades of growth in international scientific collaboration to understand the extent of the effects of reduced mobility and consider what collaboration will look like in the foreseeable future.
Digital Pathology in Drug Development: Opportunities and Challenges
Posted 20th April 2020 by Liv Sewell
We recently caught up with Dr Olulanu Aina, Scientific Director and Veterinary and Toxicological Pathologist at Janssen, about digital pathology applications in drug discovery...
9 Specifications to guide successful Automated sampling in Bioprocessing
Posted 3rd February 2020 by Liv Sewell
Automation and digitisation are becoming increasingly important in the modern environment of bioprocesses 4.0. A new wave of biopharmaceutical manufacturing is already breaking. Driven by the PAT initiative and the goal of a well-understood and optimally controlled process, the digital transformation of bioprocesses is inevitable.
AI in digital pathology; increasing workflow efficiency and patient safety
Posted 11th February 2019 by Jane Williams
In the fifth of this six-part series, the experts considered the potential cross-border solutions and challenges for Digital Pathology, as well as the evidence for improved efficiency. In this final installment, they discuss the impact of AI on industry and medical practice.
If you weren’t able to make the panel discussion, you can watch the recording here.
Cyber Crime In The Digital Age
Posted 26th February 2018 by Jane Williams
When I joined my first corporate IT-security department two decades ago (Electronic Data Processing Safety Department), I was presented with a memo between the department and the CEO.